• GenScript filed a next-day disclosure return on Aug. 20, 2026, reporting 9,272,512 new shares issued under share-based plans.
• Issuances included option exercises priced at HKD 7.08, HKD 10, HKD 5, HKD 5.39 per share.
• Restricted share awards were issued at HKD 0.01 per share.
• Issued share capital rose to 2,198,103,855 shares as of Aug. 20.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260820-12292893), on August 20, 2026, and is solely responsible for the information contained therein.